The risk race: using integrated risk management to keep pace with the pharma industry
A quick check of the global pharmaceutical (pharma) industry’s temperature shows that it is in good health: worth approximately $934.8 billion in 2017, it is estimated to reach over $1,170 billion this year. This encouraging prognosis has been aided by several factors – from rising incomes and enhanced medical infrastructures to rapid advancements in the […]
The risk race: using integrated risk management to keep pace with the pharma industry Read More »






